BioMerieux Offer For Organon Teknika Would Create $1 Bil. Diagnostics Unit
This article was originally published in The Gray Sheet
Executive Summary
BioMerieux-Pierre Fabre's Feb. 15 offer to buy Organon Teknika's diagnostic business would increase the French company's worldwide diagnostic revenues almost 44% to roughly $0.9 bil. annually.